The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis

Venous thromboembolism (VTE) complicates the clinical course of approximately 5–10% of all cancer patients. Anticoagulation of the cancer patient often presents unique challenges as these patients have both a higher risk of recurrent VTE and a higher risk of bleeding than patients without cancer. Al...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Samkari, Hanny, Connors, Jean M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115910/
https://www.ncbi.nlm.nih.gov/pubmed/30111746
http://dx.doi.org/10.3390/cancers10080271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115910/
https://www.ncbi.nlm.nih.gov/pubmed/30111746
http://dx.doi.org/10.3390/cancers10080271

Ejemplares similares